Grifols S.A.

Grifols S.A.

World Rank (Aug-2026)
2630
Market Cap (Aug-2026)
7.879 Billion USD
World Rank (Jan-05-2024)
1,723
Market Cap (Jan-05-2024)
9.535 Billion USD
World Rank (Jul-30-2023)
1,788
Market Cap (Jul-30-2023)
9.235 Billion USD
World Rank (Jan-07-2022)
1,735
Market Cap (Jan-07-2022)
11.020 Billion USD
World Rank (Jan-01-2021)
1,037
Market Cap (Jan-01-2021)
17.417 Billion USD
Headquarters Country
Spain
Top Healthcare Companies in Europe
Top Pharmaceutical Companies in Europe
Nasdaq / NYSE Code
GRFS
Employee Count
26,314
Employee Count as of Date
As on 2022
Headquarters City/State
Barcelona
World Region
Europe
World Subregion
Southern Europe
Annual Revenue in USD
8,923 Million USD
Annual Operating Income in USD
1,484 Million USD
Annual Net Income in USD
477 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
23,378 Million USD
Total Liabilities in USD
14,361 Million USD
Total Equity in USD
9,017 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
GRIFOLS S.A.
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

Pharmaceutical and healthcare company with headquarters is in Barcelona, Spain.

Annual Results Summary

GRIFOLS - Annual Results - Revenue and Net Income - in Million EUR:

Year - EndingRevenueNet Profit
Dec-20226,063208
Dec-20214,933182
Dec-20205,340708
Dec-20195,098625
Balance Sheet Summary

Total Assets as on Dec-2022 is 21,533 Million EUR.

Total Liabilities as on Dec-2022 is 13,076 Million EUR.

Total Equity as on Dec-2022 is 8,457 Million EUR.

Founded Year
1940
Stock Category
S&P EUROPE 350
Stock Exchange
Nasdaq
MCE
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share